Blomia Tropicalis (Blo t 5) IgE

If you wheeze, sneeze, or rub itchy eyes in a humid climate and the usual dust mite tests come back unhelpful, the wrong mite may be driving your symptoms. Blo t 5 (Blomia tropicalis allergen 5) IgE is a blood antibody that flags whether your immune system has become reactive to the tropical dust mite Blomia tropicalis, a different species from the Dermatophagoides mites that most standard panels test.

This matters because Blomia is the dominant indoor mite across many tropical and subtropical regions, and routine skin testing or whole-extract panels can miss it. A positive Blo t 5 result points to a real, species-specific sensitization that has been linked to asthma, allergic rhinitis, and more severe airway disease in research cohorts.

What Blo t 5 Actually Measures

Blo t 5 IgE is not the mite and not the symptom. It is a specific kind of immune antibody, called IgE, that your immune system's B cells and plasma cells (white blood cells that make antibodies) produce when your body has decided that the Blo t 5 protein is a threat. When you breathe in mite particles later, that IgE primes mast cells and basophils (immune cells in tissue and blood) to release the chemicals that cause allergy symptoms.

Because Blo t 5 is considered a major Blomia tropicalis allergen, a positive blood result is treated as a species-specific marker of true Blomia sensitization, not a general signal of dust allergy. This is the main reason this test exists separately from whole-mite IgE panels.

Asthma Risk

Blo t 5 sensitization tracks closely with asthma in places where Blomia is common. In Taiwanese asthmatic patients sensitized to Blomia tropicalis, a large majority carried Blo t 5 specific IgE. In Malaysian allergic patients, most of those with Blomia IgE recognized Blo t 5, and sensitization to it was a strong predictor for an allergic asthma diagnosis.

In asthmatic children and young adults in equatorial Africa, a substantial share had serum IgE to Blo t 5, higher than rates for several Dermatophagoides components in the same patients. Among Colombian asthmatics, higher Blo t 5 IgE levels showed up in people also sensitized to the Ascaris parasite and were linked to more emergency visits for asthma.

In a separate analysis of moderate-to-severe type 2 asthma, Blo t 5 carried higher IgE titers in the more severe phenotypes. The pattern across these studies is consistent: detectable Blo t 5 IgE is not just a sign that you react to mites, it is a sign tied to clinically meaningful airway disease.

Allergic Rhinitis and Multi-System Allergy

Blo t 5 sensitization also tracks with allergic rhinitis, the chronic nasal allergy that causes congestion, sneezing, and post-nasal drip. The Malaysian cohort showed Blo t 5 IgE as a significant risk factor for both rhinitis and asthma. In tropical pediatric cohorts, children with broader Blo t component recognition, including Blo t 5, were more likely to have combined rhinitis, asthma, and atopic dermatitis rather than a single allergy.

This is useful information for adults trying to make sense of overlapping symptoms. If you have nasal allergy plus mild wheeze plus eczema, a positive Blo t 5 result points to a single underlying driver rather than three unrelated problems.

Why It Beats Standard Dust Mite Testing in Some Regions

Blo t 5 has only limited cross-reactivity with its closest Dermatophagoides homologue Der p 5, and IgE levels to Blo t 5 are typically higher than to that homologue. That makes Blo t 5 a relatively clean marker of true Blomia sensitization rather than spillover from a Der p 5 reaction. Cross-reactivity with the related Group 21 mite allergens (such as Der p 21 and Der f 21) is more complex: at least one study found that Der f 21 could inhibit a substantial fraction of IgE binding to Blo t 5, so a Blo t 5 result in a person with strong Dermatophagoides sensitization needs to be interpreted alongside the broader component profile.

The practical consequence: in regions where Blomia dominates, standard skin prick testing with Dermatophagoides extracts can miss the actual culprit. Research from equatorial Africa, Venezuela, and Malaysia shows that without component testing, Blomia-driven disease often goes undiagnosed or gets misattributed. Commercial Blomia skin test extracts also frequently contain low or inconsistent amounts of Blo t 5, which weakens skin testing further.

Influence of Environment and Co-Infections

Two real-world factors can amplify Blo t 5 IgE. The first is environment: in the FRAAT birth cohort in Colombia, less hygienic living conditions raised the odds of Blo t 5 sensitization in children, and the IgE profile expanded across early childhood.

The second is parasite exposure. In Colombian asthmatics, IgE to Blo t 5 ran higher in people also sensitized to Ascaris, and this combined IgE profile tracked with markers of more severe asthma, including more frequent emergency visits. If you grew up in or have spent extended time in regions with high parasite exposure, your Blo t 5 result can carry more weight.

Why One Reading Is Not Enough

A single Blo t 5 IgE result tells you whether sensitization exists right now. It does not tell you whether your reactivity is rising, holding steady, or declining, which is often the more useful clinical signal. The available studies treat Blo t IgE largely as a binary marker and do not provide intra-individual variability data, so the prudent approach is to repeat testing when symptoms change, when you move climates, or when you start or stop immunotherapy.

No guideline specifies a retesting cadence for Blo t 5 IgE. As a practical, expert-opinion approach (not an established standard of care), some clinicians repeat testing 6 to 12 months after a major change such as starting immunotherapy or relocating to a different climate, and check in periodically if symptoms remain active. Trends matter more than any single number.

What an Out-of-Pattern Result Should Make You Do

A positive Blo t 5 result is not the endpoint, it is the start of a workup. Pair it with whole-extract IgE for Blomia tropicalis, Dermatophagoides pteronyssinus, and Dermatophagoides farinae to map the full mite picture. Add other Blomia components (Blo t 2, Blo t 7, Blo t 21) and Dermatophagoides components (Der p 1, Der p 2) to clarify cross-reactivity and overall severity risk.

If you have asthma or rhinitis that is not well controlled, an allergist or immunologist can use this profile to decide whether targeted allergen immunotherapy with a Blomia-containing extract is appropriate, and to set realistic expectations for response. A negative Blo t 5 in someone with mite-pattern symptoms should redirect attention to Dermatophagoides components, storage mites, or non-mite triggers.

When Results Can Be Misleading

Blood IgE and skin prick test results do not always agree. In one study of allergic patients, roughly a third had discordant results between skin prick testing and Blo t IgE measured by a standard blood IgE assay, with only fair statistical agreement. Both methods catch different patients, so neither is the final word in isolation.

• Skin test vs blood IgE mismatch: skin testing depends on the quality of the Blomia extract, which often has variable Blo t 5 content. A negative skin test does not rule out a positive blood result, or the reverse.
• Recent infection or heavy parasite exposure: can amplify IgE responses and complicate interpretation, particularly in tropical settings.
• Age effects on skin reactivity: older adults can have smaller skin wheals even when blood IgE is high, which can make blood testing more reliable.
• Cross-reactivity caveat: if you also have strong Dermatophagoides sensitization, some shared epitopes, particularly with Group 21 mite allergens such as Der f 21, can blur which mite is actually driving symptoms. Component testing is what disentangles this.

Antihistamines do not affect specific IgE measured by blood testing, so you do not need to stop them before this test. Corticosteroids are a more nuanced story: some studies have reported transient increases in total and specific IgE during systemic steroid therapy, so if you have recently had a course of oral or injected steroids, mention it to your clinician when interpreting the result. Standard pre-test fasting and timing rules do not apply to specific IgE measurement the way they do to glucose or lipid markers.